Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK, the Financial Times reported on ...
Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
3d
TipRanks on MSNGSK Executives Involved in Share Vesting and SalesGSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...
GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.
Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...
Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors.
President Donald Trump is meeting Friday with Nvidia CEO Jensen Huang, whose company designs and supplies the advanced computer chips that play an integral role in developing artificial ...
President Donald Trump met Friday with Nvidia CEO Jensen Huang, marking the first meeting between the president and the leader of a chip company at the center of the artificial intelligence gold ...
Kim, 54, has been running Takeda’s US operations since 2022and will assume the role of CEO in June next year, subject to shareholder approval, the company said in a statement Wednesday.
GSK CEO, Sir Andrew Witty said: "Reaching a conclusion in the investigation of our Chinese business is important, but this has been a deeply disappointing matter for GSK. We have and will continue ...
Prior to joining the Japanese pharma giant, Weber worked at GSK for more than two decades, leaving in March 2014 as president and GM of vaccines. Since assuming the CEO post in 2015, Weber has guided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results